816 related articles for article (PubMed ID: 15111928)
1. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
Fraser GA; Walker II;
Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
[TBL] [Abstract][Full Text] [Related]
2. Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium.
Hudspeth MP; Hill TN; Lewis JA; Van Meter E; Ragucci D
Pediatr Blood Cancer; 2010 Jul; 54(7):970-5. PubMed ID: 20135703
[TBL] [Abstract][Full Text] [Related]
3. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
[TBL] [Abstract][Full Text] [Related]
4. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
Dykewicz CA; ; ;
Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
[TBL] [Abstract][Full Text] [Related]
5. Management of CMV infection and disease in transplant patients. 27-29 February 2004.
Razonable RR; Emery VC;
Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905
[TBL] [Abstract][Full Text] [Related]
6. [Antiviral prophylaxis].
Graubner UB
Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Centers for Disease Control and Prevention recommendations for outcomes of acute otitis media.
Bauchner H; Marchant CD; Bisbee A; Heeren T; Wang B; McCabe M; Pelton S;
Pediatrics; 2006 Apr; 117(4):1009-17. PubMed ID: 16585294
[TBL] [Abstract][Full Text] [Related]
8. Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation -- single-centre experience.
Skapova D; Racil Z; Dvorakova D; Minarikova D; Mayer J
Neoplasma; 2005; 52(2):137-42. PubMed ID: 15800712
[TBL] [Abstract][Full Text] [Related]
9. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
10. Looking inside the 2003 CDC dental infection control guidelines.
Harte JA
J Calif Dent Assoc; 2004 Nov; 32(11):919-30. PubMed ID: 15651469
[TBL] [Abstract][Full Text] [Related]
11. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
Mangram AJ; Horan TC; Pearson ML; Silver LC; Jarvis WR
Am J Infect Control; 1999 Apr; 27(2):97-132; quiz 133-4; discussion 96. PubMed ID: 10196487
[TBL] [Abstract][Full Text] [Related]
12. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy.
Avery RK; Adal KA; Longworth DL; Bolwell BJ
Bone Marrow Transplant; 2000 Oct; 26(7):763-7. PubMed ID: 11042658
[TBL] [Abstract][Full Text] [Related]
13. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; Socié G
Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice.
Trifilio S; Verma A; Mehta J
Bone Marrow Transplant; 2004 Apr; 33(7):735-9. PubMed ID: 14755318
[TBL] [Abstract][Full Text] [Related]
15. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
[TBL] [Abstract][Full Text] [Related]
16. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
[TBL] [Abstract][Full Text] [Related]
17. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
18. A novel method of guideline development for the diagnosis and management of mild to moderate hypertension.
Adams JL; Fitzmaurice DA; Heath CM; Loudon RF; Riaz A; Sterne A; Thomas CP
Br J Gen Pract; 1999 Mar; 49(440):175-9. PubMed ID: 10343418
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
Ehlert K; Groll AH; Kuehn J; Vormoor J
Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
Walker CM; van Burik JA; De For TE; Weisdorf DJ
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
